Connect with us

BUSINESS

Alpine 4 Holdings Inc (OTCMKTS: ALPP) Announces the Unification of Impossible Aerospace Corporation and VAYU (US), Inc.

Published

on

Alpine 4 Holdings Inc (OTCMKTS: ALPP) has announced that its divisions, Impossible Aerospace Corporation and Vayu (US) Inc., will amalgamate to become VAYU Aerospace Corporation, Inc. The company expects the unification to be accomplished by October 1, 2021.

New company to be called Vayu Aerospace Corporation, Inc.,

The new company, Vayu Aerospace Corporation, Inc., will be situated in Ann Arbor, Michigan, at the present facility VAYU is operating. Alpine 4’s CEO, Kent Wilson, has written a letter laying out his vision for the new company.

Dear Stockholders, Stakeholders, and Personnel,

I am satisfied to announce that our two subsidiaries, Impossible Aerospace Corporation and Vayu (US), Inc., will combine to become one new company called Vayu Aerospace Corporation, Inc.

Before purchasing Impossible Aerospace and VAYU (US), Inc., I laid out three all-embracing objectives for our soon-to-be aerospace purchases. The conclusion of working through these all-embracing objectives exposed the significance of the merger of these two great companies into one.

The first objective was to influence the tens of millions of dollars in R&D accrued between the two companies into a front-runner in the commercial drone space. The commercial drone business is still in its early stages and is projected to grow from $4.4 billion in 2018 to $63 billion by 2025. Within the commercial drone business, we believe that the three airframes (US-1, G1, and G2) are well-positioned to grasp market share in numerous sectors, including cargo, surveillance, and military applications.

The second all-embracing goal I laid out was to guide future R&D around a specific drive. That drive is to shape our drone airframes to be the go-to airframes for cargo and logistics.

The third overarching goal was to authorize the leadership to depart from the rationale of their former stakeholders. This parting meant a new way of thinking about their own companies. 

Reimbursements of the grouping of the two businesses

An enhanced and more focused supply chain: Numerous separate and non-uniform hardware pieces in the US-1 and G1 existing numerous supply chain subjects in a post-COVID-19 world. Exploiting the supply chain pains between airframes will lower the price tag, upsurge product obtainability, and improve Vayu’s ability to overhaul aircraft in the field or one of our overhaul amenities.

R&D rationalization: The drone aerospace subdivision is tremendously capital exhaustive due to rigorous R&D expenditures that need to be understood to advance and upgrade airframes and avionic platforms. IA and VAYU collective has spent over 20 million dollars constructing their airframes to bring them to market. This type of expenditure will need to endure for some time, and uniting both airframes into one development team will significantly improve the consistency of the airframes and upsurge our R&D efficacy.

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

BUSINESS

Khiron Life Sciences Corp (OTCMKTS: KHRNF) Accelerating Its Expansion and Presence In Mexico and Brazil

Published

on

Khiron Life Sciences Corp (OTCMKTS: KHRNF) has announced the successful completion of its first medical cannabis sale in Brazil. The company plans to leverage its clinical distribution and production assets in Latin America plus marketing contracts with pharmaceutical distributors to expand its presence in Brazil, where there is a market of more than 200 million people.

Khiron enhancing its presence in Brazil

The company’s Director and CEO Alvaro Torres said, “Our initial export to the Brazilian market represents an important first step toward opening a large, underserved market where patients face high barriers to access. By providing patients with affordable high-quality products, and an unparalleled patient experience, we see an opportunity to disrupt the Brazilian market and deliver on our mission of improving patients lives. Khiron is already treating thousands of patients in Colombia, Peru, UK and Germany, with positive outcomes. In due course, we plan to bring our successful Zerenia clinic model to Brazil, as we have done in Peru and Colombia.”

So far, the company has created two partnerships in Brazil to enhance medical cannabis education and awareness for care providers across the country. Khiron has an exclusive distribution agreement with Medlive. Also, the company entered a marketing contract with a medical distributor, TAIMIN.

Khiron expanding to Mexico

The company is accelerating its entry into Mexico, where there is a large market for around 11.7 million patients in need of medical cannabis remedies. Khiron is leveraging the National Strategic project designation in Columbia for authorization to include Mexico as a destination within the international export quota. There more than 700 kg of high-THC extract available for export to Mexico. Already the company has finalized a manufacturing and distribution agreement for medical cannabis products in Mexico. The company will launch Zerenia clinics in major Mexican cities in 2021, replicating the vertically integrated model in Peru and Columbia. 

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

PharmaCyte Biotech Inc. (OTCMKTS: PMCB) Announces Reverse Stock Split, Branded Legacy Inc. (OTCMKTS: BLEG) adds 15 Retail Grocery Accounts

Published

on

PharmaCyte Biotech Inc. (OTCMKTS: PMCB) has announced plans to effect a 1 for 1,500 reverse common stock split leaving it with around 1.6 million outstanding and issued shares. Once the market opens, the company’s common shares will commence trading on the OTCQB on a split-adjusted basis from July 12, 2021. 

PharmaCyte announces reverse stock split 

The move seeks to reduce PharmaCyte’s outstanding common shares from around 2.4 million to $1.6 million. Interestingly, there will be proportional adjustments to PharmaCyte’s outstanding warrants and stock options. 

Kenneth L. Waggoner, the company’s CEO, stated, “With approximately 1.6 million shares outstanding, we believe this change will make it easier for investors to trade in our stock and is a necessary step before the Company’s common stock can be listed on a national stock exchange like Nasdaq, which is our expectation.”

Branded Legacy adds 15 new retail grocery accounts 

Branded Legacy Inc. (OTCMKTS: BLEG) has announced 15 new retail grocery accounts in Central Florida. The company is gaining momentum with new hires introducing Elev8 Hemp CBD-infused Ice tea at two grocery chains on a pilot basis. The CBD iced tea will be availed in five Fancy Fruit & Produce stores and ten Bravo Supermarkets. 

Matthew Nichols, Branded Legacy VP, said, Working with the right people is critical in any company. We are pleased to see the activity and results in such a short period of time. It’s a precursor of what’s to come. We are very pleased with the recent growth. We are seeing sales growing on our website, social, Amazon, and brick-and-mortar. There have been some hurdles to overcome, but we now have the right team in place. We expect to see a strong influx in sales in the third and fourth quarter.”

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Ayr Wellness Inc. (OTCMKTS: AYRWF) Launches Seven Hills Flower and Opens 37th Location

Published

on

Ayr Wellness Inc. (OTCMKTS: AYRWF) has announced the opening of its 37th open location in Florida, Liberty Health Sciences. The 1,500 square feet dispensary is situated at 826 Duval Street, Key West Florida, 33040.

Ayr opens its 37th location in Florida

 It sits on Downtown Key West’s main strip with a range of nearby attractions, shops, and restaurants. The location features a variety of flower products, including the Ayr Wellness’ recently launched Big Pete’s cookies and Origin concentrates. 

Ayr CEO Jonathan Sandelman said, “We are continuing to execute on our Florida plan, opening dispensaries in prime locations while continually enhancing our cultivation efforts to make us the highest quality cultivator at scale in the state. Our updated product offerings, including a diversified strain selection and launch of Origyn Extracts and Big Pete’s Cookies, have already contributed to an improved customer experience, and the results are beginning to show.”

Ayr launches Seven Hills flower in Pennsylvania. 

The company also announced the launch of Seven Hills flower in Pennsylvania following the Revel branded flower’s introduction in May. Seven Hills will be the company’s first offering from its Pottsville, Pennsylvania facility. The Seven Hills sales have commenced and will be available in the company’s Plymouth Meeting and Gibsonia dispensaries. The initial launch includes a variety of strains that include Space Monkey, Sapphire, Wedding Crasher, Mendo, Chem 4, and Lemon Kush Headband, among others.

Sandelman stated, “Our mission is to be the highest quality cultivator at scale in every market that we enter, and Pennsylvania is no exception. We are excited to add Seven Hills to our premium offerings in the Commonwealth, where quality flower is in high demand. I am particularly thrilled to be here with the team today on 7/7 to celebrate the launch of Seven Hills, a product that truly represents the people and community of Pottsville, PA.”

[optin-monster-shortcode id="lt2ftjs5qhrst1pzmmap"] *Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories